Patrizio Armeni

TL;DR: It is shown that haemophilia is associated with a substantial economic burden and impaired HRQOL and the driving role of drugs in costs is shown to differ between children and adults.

TL;DR: The average annual cost per patient with DMD in eight European countries adopting a social perspective is estimated, which is the first study with such a wide perspective and the results on costs show a considerable gap between Eastern and Western European countries.

TL;DR: Quality of life of patients with haemophilia and their caregivers improved and it influences positively on consumed resources and on their contribution to the social-economic system.

TL;DR: acceptable definitions of innovation in relation to medical devices are summarized based on a systematic review of the academic literature in the field to foster present and future innovativeness in the system.

TL;DR: Compared to MT alone and given conventional threshold values, MitraClip can be considered a cost-effective procedure and is in line or superior to the one of other non-pharmaceutical strategies for heart failure.